Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Eleni Papakonstantinou, Ioannis Bonovolias, Michael Roth, Michael Tamm, Desiree Schumann, Florent Baty, Renaud Louis, Branislava Milenkovic, Wim Boersma, Bram Stieltjes, Konstantinos Kostikas, Francesco Blasi, Joachim G. Aerts, Gernot G.U. Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte, Daiana Stolz. Serum levels of hyaluronic acid are associated with COPD severity and predict survival. Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018

Member's Comments

No comment yet.

Related content which might interest you: Serum uric acid levels among COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Serum uric acid levels among patients with COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum uric acid as a predictor of mortality and future exacerbations of COPD Source: Eur Respir J 2014; 43: 43-53 Year: 2004 Total serum bilirubin levels are not related to the severity of COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Assessment of serum uric acid in COPD exacerbations Source: International Congress 2017 – Markers of COPD progression Year: 2017 Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 Characterisation of asthma subgroups associated with circulating YKL-40 levels Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017 Year: 2017 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 The relationship between the serum YKL-40 level and severity of asthma Source: Annual Congress 2012 - Asthma management Year: 2012 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020